Organogenesis Holdings's market cap is currently $424.95M. The company's EPS TTM is $-0.056; its P/E ratio is ―; Organogenesis Holdings is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 433.14M	$ 450.89M	$ 468.06M	$ 338.30M	$ 260.98M
Gross Profit	$ 326.66M	$ 345.87M	$ 353.86M	$ 250.98M	$ 185.03M
Operating Income	$ 12.53M	$ 22.30M	$ 72.92M	$ 27.41M	$ -29.46M
EBITDA	$ 36.03M	$ 40.32M	$ 87.00M	$ 37.23M	$ -21.88M
Net Income	$ 4.95M	$ 15.53M	$ 94.20M	$ 17.23M	$ -40.45M
Balance Sheet
Cash & Short-Term Investments	$ 104.34M	$ 102.48M	$ 113.93M	$ 84.39M	$ 60.17M
Total Assets	$ 460.02M	$ 449.36M	$ 443.26M	$ 294.49M	$ 220.69M
Total Debt	$ 119.35M	$ 123.79M	$ 132.30M	$ 84.77M	$ 100.61M
Net Debt	$ 15.51M	$ 21.31M	$ 18.37M	$ 377.00K	$ 40.43M
Total Liabilities	$ 181.36M	$ 183.69M	$ 201.22M	$ 148.41M	$ 165.10M
Stockholders' Equity	$ 278.66M	$ 265.67M	$ 242.03M	$ 146.08M	$ 55.58M
Cash Flow
Free Cash Flow	$ 6.55M	$ -9.04M	$ 30.76M	$ -14.34M	$ -39.76M
Operating Cash Flow	$ 30.92M	$ 24.86M	$ 61.98M	$ 6.80M	$ -33.53M
Investing Cash Flow	$ -24.36M	$ -33.90M	$ -31.22M	$ -24.83M	$ -6.23M
Financing Cash Flow	$ -5.50M	$ -2.20M	$ -1.04M	$ 42.47M	$ 78.73M

Currency in USD

Organogenesis Holdings Earnings and Revenue History

Income Statement >

Organogenesis Holdings Debt to Assets

Balance Sheet >

Organogenesis Holdings Cash Flow

Cash Flow >

Organogenesis Holdings Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing